Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 506 resultados

SUCCESSion: Probing the malignant potential of mutant clones in healthy mammary tissue by successive mutagenesi... VIB VZW tramitó un HORIZON EUROPE: ERC-2024-STG Mutant cells are abundant in normal tissues, but only very few will transform into life-threatening cancer. The triggers for these mutant cl...
2024-12-01 - 2029-11-30 | Financiado

EmoDevo: Building emotional circuits interfacing intrinsic programs with early life experiences VIB VZW tramitó un HORIZON EUROPE: ERC-2024-STG Emotion regulation and responses to fear and stress are vital for survival and interactions with the environment. Within the brain, the amyg...
2024-09-25 - 2029-09-30 | Financiado

ENRICH T-BRAIN: Immune mechanisms of experience induced brain plasticity the contribution of brain resident T cells VIB VZW tramitó un HORIZON EUROPE: ERC-2024-STG T cells are part of the adaptive immune response. Breaking the dogma of the brain immune privilege I demonstrated the presence of T cells i...
2024-09-16 - 2029-12-31 | Financiado

SciLifeLab PULSE: SciLifeLab Programme for fUture Leaders in life SciencE SciLifeLab PULSE is a MSCA-COFUND postdoctoral programme of excellence in Life Sciences coordinated by the Swedish research infrastructure S...
2024-09-16 - 2030-08-31 | Financiado

ARISE2: Career Accelerator for Research Infrastructure Scientists 2nd generation VIB VZW participó en un HORIZON EUROPE: HORIZON-MSCA-2023-COFUND-01 The ARISE2 program will train 50 postdoctoral fellows for roles as research infrastructure (RI) scientists—highly skilled and much-needed sc...
2024-09-12 - 2029-12-31 | Financiado

SUCCESSion: Probing the malignant potential of mutant clones in healthy mammary tissue by successive mutagenesi... VIB VZW tramitó un HORIZON EUROPE: ERC-2024-STG Mutant cells are abundant in normal tissues, but only very few will transform into life-threatening cancer. The triggers for these mutant cl...
2024-09-06 - 2029-11-30 | Financiado

CRYSTAL-SHINE: A nanobody imaging tool to detect protein crystals and predict therapeutic response in asthmatics VIB VZW tramitó un HORIZON EUROPE: ERC-2024-POC Asthma is characterized by airway obstruction, causing difficulty in breathing. The major cause of therapy resistant obstruction is mucus pl...
2024-09-01 - 2026-02-28 | Financiado

GALOMOD: Gamma-secretase allosteric modulation as preventive therapy in Alzheimer’s Disease VIB VZW tramitó un HORIZON EUROPE: ERC-2023-POC The recent advent of therapeutic Aβ-antibodies has validated amyloid plaques as drug targets in Alzheimer’s Disease (AD). They remain expens...
2024-09-01 - 2026-02-28 | Financiado

GALOMOD: Gamma secretase allosteric modulation as preventive therapy in Alzheimer s Disease VIB VZW tramitó un HORIZON EUROPE: ERC-2023-POC The recent advent of therapeutic Aβ-antibodies has validated amyloid plaques as drug targets in Alzheimer’s Disease (AD). They remain expens...
2024-08-29 - 2026-02-28 | Financiado

ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE VIB VZW participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado

ODIN-MPox: Implementing wastewater and environmental surveillance for Mpox in Sub Saharan Africa VIB VZW participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox Mpox, a re-emerging viral zoonotic disease, has recently posed significant public health challenges in sub-Saharan Africa, particularly in t...
2024-08-07 - 2026-07-31 | Financiado

CRYSTAL-SHINE: A nanobody imaging tool to detect protein crystals and predict therapeutic response in asthmatics VIB VZW tramitó un HORIZON EUROPE: ERC-2024-POC Asthma is characterized by airway obstruction, causing difficulty in breathing. The major cause of therapy resistant obstruction is mucus pl...
2024-07-24 - 2026-02-28 | Financiado

MIRACLE: Integrated multi angle research and training network to eradicate leukemia minimal residual disease An estimated 300,000 new cases of leukemia are diagnosed each year globally. The most common form of acute leukemia is acute myeloid leukemi...
2024-06-28 - 2028-11-30 | Financiado

HEATDDR: Harnessing the DNA Damage Response to improve plant tolerance to heat stress In the context of climate change, Europe is facing new challenges that are threatening food security. There is thus an urgent need for the d...
2024-06-06 - 2029-02-28 | Financiado

Allosteris: Allosteric modulation of immune checkpoint complexes as a new mode of therapeutic intervention in im... VIB VZW tramitó un HORIZON EUROPE: ERC-2023-ADG The fastidious balance of our immune system to fight infections or cancer while avoiding autoimmune reactions is regulated by coinhibitory a...
2024-05-22 - 2029-05-31 | Financiado

VLAAMS INSTITUUT BIOTECHNOLOGIE FLANDER...